<DOC>
	<DOCNO>NCT01890343</DOCNO>
	<brief_summary>Study 18F-AV-45-010 design evaluate cerebral uptake florbetapir 18F measure PET image frontotemporal disorder ( FTD ) comparison cognitively normal volunteer subject Alzheimer 's disease ( AD ) .</brief_summary>
	<brief_title>Imaging Characteristics Florbetapir 18F Patients With Frontotemporal Dementia , Alzheimer 's Disease Normal Controls .</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Frontotemporal Dementia</mesh_term>
	<mesh_term>Aphasia , Primary Progressive</mesh_term>
	<mesh_term>Pick Disease Brain</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>AD : Male female &gt; = 50 year age Meet National Institute Neurological Communicative Disorders Stroke ( NINCDS ) criteria probable AD Mini Mental State Examination ( MMSE ) score screen 10 24 inclusive Have caregiver report mental status activity daily live ( ADL ) Give informed consent caregiver give consent subject assent . FTD : Male female &gt; = 45 year age Meet consensus criterion FTD mild moderate disease severity . Have caregiver report mental status ADL Give inform consent caregiver give consent subject assent . CN : Male female &gt; = 45 year age Have MMSE &gt; = 29 Give inform consent Have history current clinically significant neurologic disease ( AD FTD , applicable ) , diagnosis dementing/neurodegenerative disease , diagnosis mixed dementia Evidence MRI biomarkers suggest etiology dementia AD FTD , applicable case CN subject evidence indicate presence AD , FTD type neurologic pathology Have current clinically significant cardiovascular disease , screen ECG abnormality , psychiatric disease , endocrine metabolic disease , pulmonary , renal hepatic impairment , cancer infectious disease Have recent history alcohol substance abuse dependence Women childbearing potential permanently surgically sterile , refrain sexual activity use adequate contraception . Require medication narrow therapeutic window , receive investigational medication , participate trial investigational medication within last 30 day Have ever participate study amyloid target agent Have radiopharmaceutical imaging treatment procedure within 7 day image , define protocol</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>